Comparison of the Efficacy Between RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) and Dose Dense Chemotherapy Regimens (RCHOP-14, R-DHAP- R-EPOCH) on Survival as a First Line Treatment in Lebanese Patients with Non-Hodgkin Lymphoma

Comparison of the Efficacy Between RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) and Dose Dense Chemotherapy Regimens (RCHOP-14, R-DHAP- R-EPOCH) on Survival as a First Line Treatment in Lebanese Patients with Non-Hodgkin Lymphoma

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia Vol. 19; pp. S250 - S251
Main Authors: Antoun, Leony, Touma, Elsie, Nasr, Fadi, Massoud, Marcel, Rizk, Rita, Salem, Mansour, Zeghondy, Jean, Hallit, Souheil, Chahine, Georges
Format: Journal Article
Language:English
Published: Elsevier Inc 01-09-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2019.07.157